Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Alvopetro Energy Ltd. (TSXV:ALV,OTC:ALVOF) (OTCQX: ALVOF) ("Alvopetro" or the "Company") announces our reserves as at December 31, 2025 with total proved ("1P") reserves of 8.1 MMboe and total proved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results